Form D · Biotechnology
Ausel, Inc.
Carlsbad, CA · CIK 0002124022
Offering snapshot reported Nov 4, 2026 · SEC filing
- Reported sold
- $120K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 22, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2026 | Initial | $120,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-603570
Source: Form D, filed Nov 4, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Ainslie | Director, Executive |
| Paul Ainslie | Director |
| Robert Ainslie | Promoter |
| Prisco Piscitelli | Executive |
| Paul Evan Shockley | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2871 Rancho Cortes
Carlsbad, CA, 92009
Carlsbad, CA, 92009